However, neither prognostic nor predictive significance has yet been found for NLR and LMR in a small cohort of canine patients which received anti-CSPG4 immunotherapy (see below), nor any correlations to histological/immunohistochemical parameters of melanoma well-known prognostic factors (43). This evidence concerns the gene CSPG4 and melanoma.